(-0.43%) 5 027.50 points
(-0.35%) 37 874 points
(-0.67%) 17 430 points
(-0.53%) $82.29
(-0.17%) $1.754
(-0.05%) $2 396.90
(-0.16%) $28.34
(-1.06%) $944.40
(-0.09%) $0.938
(-0.02%) $11.04
(-0.03%) $0.804
(-0.78%) $93.17
Live Chart Being Loaded With Signals
Senzime AB (publ), a medical device company, develops and markets patient monitoring systems to monitor patients under anesthesia in Europe, Oceania, Asia, Canada, and the United States...
Stats | |
---|---|
Today's Volume | 65 637.00 |
Average Volume | 139 880 |
Market Cap | 588.32M |
EPS | SEK0 ( 2024-02-15 ) |
Next earnings date | ( SEK-0.300 ) 2024-05-06 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -3.29 |
ATR14 | SEK0.0360 (0.62%) |
Volume Correlation
Senzime AB (publ) Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Senzime AB (publ) Correlation - Currency/Commodity
Senzime AB (publ) Financials
Annual | 2023 |
Revenue: | SEK35.75M |
Gross Profit: | SEK7.70M (21.55 %) |
EPS: | SEK-1.450 |
Q4 | 2023 |
Revenue: | SEK10.85M |
Gross Profit: | SEK3.08M (28.37 %) |
EPS: | SEK-0.330 |
Q3 | 2023 |
Revenue: | SEK9.15M |
Gross Profit: | SEK2.25M (24.55 %) |
EPS: | SEK-0.330 |
Q2 | 2023 |
Revenue: | SEK8.46M |
Gross Profit: | SEK1.84M (21.79 %) |
EPS: | SEK-0.420 |
Financial Reports:
No articles found.
Senzime AB (publ)
Senzime AB (publ), a medical device company, develops and markets patient monitoring systems to monitor patients under anesthesia in Europe, Oceania, Asia, Canada, and the United States. The company offers TetraGraph, a monitor that stimulates, measures, analyzes, and displays muscle function in surgical patients receiving neuromuscular blocking agents; TetraSens electrode array, which has two proximal stimulating electrodes for recording and reference; TetraConnect, a data management portal that helps clinician to access, view, and export data records from the TetraGraph in PDF or Excel format; TetraGraph Device Connectivity, which transfers data from the TetraGraph Monitor to patient monitoring systems; and TetraGraph Philips Interface that enables the transmission of neuromuscular monitoring parameters, TOFC, TOFR, PTC, and TOF bars to Philips patient monitors, as well as TetraGraph readings are displayed on the Philips Intellivue Monitor. It also develops CliniSenz Analyzer for postoperative and continuous patient monitoring in hospital environments; and Onzurf Probe, a sterile CE-marked single use product based on micro-dialysis technology that enables continuous sampling from gastro-intestinal organs, such as esophagus, stomach, and liver. Senzime AB (publ) has a strategic license and connectivity agreement with Masimo to develop and market the TetraGraph Smart Cable Module that connects directly to Root monitoring system, as well as to their digital hubs to interface with the hospital clinical information system/electronic health records. The company was incorporated in 1999 and is based in Uppsala, Sweden.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators